Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Autoimmunity and inflammation in myelodysplastic syndromes
Ofir Wolach
, Richard Stone
Dana-Farber Cancer Institute
Research output
:
Contribution to journal
›
Review article
›
peer-review
44
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Autoimmunity and inflammation in myelodysplastic syndromes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Inflammation
100%
Myelodysplastic Syndrome
100%
Autoimmunity
100%
Autoimmune Disease
87%
Inflammatory Conditions
87%
Vasculitis
25%
Immunosuppressive Drugs
12%
Clinical Manifestations
12%
Genetic Heterogeneity
12%
Adverse Outcomes
12%
Systemic Disease
12%
Young Patients
12%
Cellular Immune Response
12%
Multiple Organs
12%
Common Pathway
12%
Direct Therapy
12%
Hypomethylating Agents
12%
Steroid Use
12%
Sweet Syndrome
12%
Quality of Life Impact
12%
Inflammatory Arthritis
12%
Connective Tissue Disease
12%
Constitutional Symptoms
12%
Hypersecretion
12%
High-risk Myelodysplastic Syndrome
12%
Noninfectious Fever
12%
Condition Clusters
12%
Immune Deregulation
12%
Immunology and Microbiology
Autoimmunity
100%
Vasculitis
100%
Immunosuppressive Drug
50%
Cytokine
50%
Inflammatory Arthritis
50%
Genetic Heterogeneity
50%
Connective Tissue
50%
Medicine and Dentistry
Myelodysplastic Syndrome
100%
Autoimmunity
100%
Serositis
77%
Vasculitis
22%
Quality of Life
11%
Cytokine
11%
Systemic Disease
11%
Rheumatoid Arthritis
11%
Adverse Outcome
11%
Immunosuppressive Drug
11%
Hypomethylating Agent
11%
Acute Febrile Neutrophilic Dermatosis
11%
Connective Tissue Disease
11%
Genetic Heterogeneity
11%
Constitutional Symptoms
11%